vVardis Prepares US IPO Above $1 Billion With JPMorgan and Goldman Sachs

2 articles · Updated · Bloomberg · Jun 1

Swiss dental startup vVardis is working on a US IPO that could come this year, according to people familiar with the matter.
JPMorgan Chase and Goldman Sachs have been hired to help lead the listing, signaling the company has moved into formal preparation for the offering.
More than $1 billion is the valuation benchmark: vVardis was valued above that level in an April funding round and is expected to seek a higher price in the IPO.
Founded by sisters Haley and Goly Abivardi, the Zug-based company is testing whether investor appetite for healthcare startups can support a richer public-market valuation.

With a $1B+ valuation, can two sisters' drill-free innovation disrupt the dental industry?

Can a revolutionary peptide make the dreaded dental drill a thing of the past?